Citation: Ana Marote, Nathalie Barroca, Rui Vitorino, Raquel M. Silva, Maria H.V. Fernandes, Paula M. Vilarinho, Odete A.B. da Cruz e Silva, Sandra I. Vieira. A proteomic analysis of the interactions between poly(L-lactic acid) nanofibers and SH-SY5Y neuronal-like cells[J]. AIMS Molecular Science, 2016, 3(4): 661-682. doi: 10.3934/molsci.2016.4.661
[1] | Jin Hwan Do . Genome-wide transcriptional comparison of MPP+ treated human neuroblastoma cells with the state space model. AIMS Molecular Science, 2015, 2(4): 440-460. doi: 10.3934/molsci.2015.4.440 |
[2] | Davide Lovisolo, Marianna Dionisi, Federico A. Ruffinatti, Carla Distasi . Nanoparticles and potential neurotoxicity: focus on molecular mechanisms. AIMS Molecular Science, 2018, 5(1): 1-13. doi: 10.3934/molsci.2018.1.1 |
[3] | Jade Sternberg, Miriam Wankell, V. Nathan Subramaniam, Lionel W. Hebbard . The functional roles of T-cadherin in mammalian biology. AIMS Molecular Science, 2017, 4(1): 62-81. doi: 10.3934/molsci.2017.1.62 |
[4] | Carlos Gutierrez-Merino, Dorinda Marques-da-Silva, Sofia Fortalezas, Alejandro K. Samhan-Arias . The critical role of lipid rafts nanodomains in the cross-talk between calcium and reactive oxygen and nitrogen species in cerebellar granule neurons apoptosis by extracellular potassium deprivation. AIMS Molecular Science, 2016, 3(1): 12-29. doi: 10.3934/molsci.2016.1.12 |
[5] | Navid J. Ayon . Features, roles and chiral analyses of proteinogenic amino acids. AIMS Molecular Science, 2020, 7(3): 229-268. doi: 10.3934/molsci.2020011 |
[6] | Jin Hwan Do . Apomorphine-induced pathway perturbation in MPP+-treated SH-SY5Y cells. AIMS Molecular Science, 2017, 4(3): 271-287. doi: 10.3934/molsci.2017.3.271 |
[7] | Abdulrahman Mahmoud Dogara, Ateeq Ahmed Al-Zahrani, Sarwan W. Bradosty, Saber W. Hamad, Aisha Abdullahi Mahmud, Hussain D. Almalki, Mustapha Abdullahi, Abubakar Abdullahi Lema, Hasan Nudin Nur Fatihah . In-vitro biological activity and in-silico studies of some volatile phytochemicals from the ethanol extract of Eugenia uniflora. AIMS Molecular Science, 2024, 11(3): 303-321. doi: 10.3934/molsci.2024018 |
[8] | Fatima Al-Hashimi, Salvador J. Diaz-Cano . Multi-target analysis of neoplasms for the evaluation of tumor progression: stochastic approach of biologic processes. AIMS Molecular Science, 2018, 5(1): 14-62. doi: 10.3934/molsci.2018.1.14 |
[9] | Marco Feligioni, Serena Marcelli, Erin Knock, Urooba Nadeem, Ottavio Arancio, Paul E. Fraser . SUMO modulation of protein aggregation and degradation. AIMS Molecular Science, 2015, 2(4): 382-410. doi: 10.3934/molsci.2015.4.382 |
[10] | Jian Zou, Fulton T. Crews . Glutamate/NMDA excitotoxicity and HMGB1/TLR4 neuroimmune toxicity converge as components of neurodegeneration. AIMS Molecular Science, 2015, 2(2): 77-100. doi: 10.3934/molsci.2015.2.77 |
The development of scaffolds that provide cues to induce faster tissue regeneration is a major field of tissue engineering. Biodegradable scaffolds based on materials such as polyglycolic acid, type-I collagen, and poly(85:15/L:D) lactide-ɛ-caprolactone have been used for nerve regeneration purposes [1,2,3]. These platforms aim to improve adhesion, proliferation and differentiation of neuronal precursor cells and neurons, and may include chemical and physical cues that optimize those processes. Neurons can improve their differentiation by responding to electric and topographical features present in their microenvironment. Nanofibrous scaffolds have been observed to help neuronal differentiation as neurites grow along the nanofibers meshes [2,3,4,5,6,7]. Electrical stimuli have also been shown to improve neuronal development and function [1,3,8,9,10], and can be delivered by piezoelectric materials. These have the ability to produce electricity in response to mechanical stress, in the absence of any external energy supply. Nanofibers-based platforms prepared from piezoelectric materials are thus promising nanomaterials for neuroregeneration [2,7,4,11,12]. Examples of nanofibrous piezoelectric scaffolds used to enhance cellular neuritogenesis include scaffolds based on annealed polyvinylidene fluoride-trifluoroethylene (PVDF-TrFE). These can enhance neuritic extension in dorsal root ganglion [13] and promote differentiation of human neural progenitor cells [14]. However, PVDF is a non-degradable polymer.
Poly (L-lactic) acid (PLLA) is a FDA-approved synthetic piezoelectric polymer that possesses significant advantages over other piezoelectric materials tested for neural repair so far, including its biodegradability. PLLA, as other helical polymers like polypeptides, generates shear piezoelectricity depending on the mechanical orientation of its macromolecules in the crystalline and quasi-crystalline regions. It can further present tensile piezoelectricity and a controllable polarization after an appropriate electrical poling that induces the orientation of the dipoles in its molecules [15]. In bone, the PLLA piezoelectric character can induce electric fields that stimulate osteocytes activity and accelerate bone repair [16]. The biocompatibility and biodegradability of PLLA enhance its potential for neural tissue engineering, as observed both in vitro [4,5,6,7,11,12,17,18] and in vivo [19]. In 2005, Yang and colleagues reported the first electrospun aligned PLLA scaffold for neural application, showing that neural stem cells differentiate when cultured on these PLLA nanofibrous scaffolds [4,11]. Thenceforward, several papers have explored the ability of PLLA nanofibers to promote neuritic outgrowth [4,3,6,10,17], and our group has proven that electrical polarization of PLLA nanofibers further enhances their neuritogenic effect (unpublished data).
Regardless, the molecular and cellular alterations induced by the PLLA nanofibrous platforms to their target cells are far from clarified. At the cellular level, electrical stimulation and the nanofibers’ topology can initiate molecular signaling for cellular adhesion, neuroprotection, and cytoskeleton remodeling processes. These are crucial in neuronal regeneration to de novo activate specific genes and stimulate local protein synthesis leading to structural remodeling of the injured neuron required, e.g., to form new growth cones [9]. The interaction of neuronal cells with PLLA electrospun nanofibers was recently evaluated [20]. These authors have used the human neuroblastoma SH-SY5Y cell line, a widely used in vitro model of neuronal differentiation [21], and unraveled a role for integrin and increased pERK in the PLLA nanofibers-SH-SY5Y cell interaction [20]. In this study, we aimed to further evaluate SH-SY5Y cellular processes and molecular pathways altered in response to PLLA nanofibers through a high-throughput proteomic analysis. Major cellular processes and signaling pathways influenced by the exposure of SH-SY5Y cells to the PLLA nanofibrous platforms were thus analyzed by mass spectrometry. These were related to cell viability and morphology, and to protein levels of key molecules. Our results show alterations of the cellular proteome towards the promotion of neuronal differentiation.
PLLA-based nanofibers were produced by electrospinning as follows. A 2% wt/wt polymer solution in a mixture of dichloromethane (DMC; Sigma-Aldrich) and n, n-dimethyl-formamide (DMF; Sigma-Aldrich) was prepared. PLLA pellets were first dissolved in DMC at 30 ºC. After complete dissolution, DMF was added to a final DMC:DMF 70:30 proportion. PLLA solution was electrospun in a Nanon-01A electrospinning machine (MECC CO., LTD, Japan). The solution was poured in a plastic syringe and the feeding processed through a 27-G needle (inner diameter ±0.41 mm) at a 0.5 mL/h feeding rate. The needle-to-collector distance was established to 15 cm and voltage about 15 kV were applied. PLLA-based nanofibers were produced using a collector rotation speed of 150 rpm.
The morphology of the PLLA nanofibers was examined by scanning electron microscopy (SEM) (Hitachi S-4100, Japan) at a 25 kV accelerating voltage, using gold-sputtered samples. The average fibers’ diameter was determined from SEM photos by selecting arbitrary areas of the meshes and measuring 200 fibers in 5000× magnified SEM micrographs (Digital Micrograph® software). The diameter of larger fibers was calculated as an average of 30 measurements.
Before cell seeding, PLLA nanofibers were cut into squares of 1 cm × 1 cm and sterilized with 70% ethanol for 5 min. Following one wash with distilled water and two with phosphate buffer saline (PBS), the materials were allowed to dry in the laminar flux chamber.
PLLA-based nanofibers and control wells (made of polystyrene) were coated with laminin following the physical adsorption method [22]. For that, control plates and PLLA nanofibers in wells were incubated overnight at 4 ºC in a 10 mg/mL laminin solution that was prepared by diluting a stock solution (Sigma-Aldrich) in sterile PBS. After removing the laminin solution from the well and before use, the samples were washed with sterile PBS and water for 5 min, which allowed the meshes to deposit at the bottom of the wells without floating.
The neuroblastoma SH-SY5Y cell line (ATCC, Barcelona, Spain; CLR-2266) was maintained at 37 ºC in a humidified atmosphere of 5% CO2, in 10% fetal bovine serum (FBS) minimal essential medium (MEM):F12 (1:1), with 2 mM L-glutamine, 100 U/mL penicillin and 100 mg/mL of a Streptomycin/Penicillin/Amphotericin solution (Gibco). Cells were split at 70-80% confluence.
The ability of PLLA nanofibers to promote SH-SY5Y cells adhesion was initially tested [22]. For that, 1 × 105 cells/cm2 were seeded on previously sterilized nanofibers, coated or not with laminin, and left at 37 ºC in a humidified atmosphere of 5% CO2 for 2 h. After that, cell media were collected to count the number of non-adherent cells using the Trypan blue assay. The percentage of adherent cells was subsequently calculated based on the number of cells initially seeded (taken as 100%).
The effects of PLLA-based nanofibers were evaluated using mass spectrometry. SH-SY5Y cells were cultured for 11 days onto PLLA-based nanofibers, collected with boiling 1% SDS, and mass-normalized aliquots of these lysates were subjected to electrophoresis on a 5-20% gradient SDS-PAGE. The resulting gel was incubated with the Brilliant Blue G (Sigma) staining solution for 20 min to visualize and mark bands, and further washed out with the distaining solution overnight until the background was clear. Afterwards, bands of interest were cut out of the gel using a sterile scalpel and kept at −20 ºC for further analysis. Protein bands manually excised from SDS-PAGE gel were destained with 25 mM ammonium bicarbonate/50% acetonitrile and dried under vacuum (SpeedVac®, Thermo Savant, USA). The dried gel pieces were rehydrated with 25 μL of 10 µg/mL trypsin (Promega V5111) in 50 mM ammonium bicarbonate and digested ON at 37 ºC. Tryptic peptides were extracted from the gel with 10% formic acid/50% acetonitrile, dried in a vacuum concentrator and re-suspended in 10 µL of a 50% acetonitrile/0.1% formic acid solution. Separation of tryptic peptides by nano-HPLC was performed on the module separation Ultimate 3000 (Dionex, Amsterdam) using a capillary column (Pepmap100 C18; 3 μm particle size, 0.75 μm internal diameter, 15 cm in length). A gradient of solvent A [water/acetonitrile/trifluoroacetic acid (98:2:0.05, v/v/v)] to solvent B [water/acetonitrile/trifluoroacetic acid (10:90:0.045, v/v/v)] was used. The separation of 2 μg/μL sample was performed using a linear gradient (5-50% B for 30 min, 50-70% B for 10 min and 70-5% A for 5 min) with a flow rate of 0.3 μL/min. The eluted peptides were mixed with a continuous flow of α-CHCA matrix solution (270 nL/min, 2 mg/mL in 70% ACN/0.1% TFA and internal standard Glu-Fib at 15 ftmol) and applied directly on a MALDI plate in 7 seconds fractions using an automatic fraction collector Probot (Dionex, Amsterdam).
Mass spectra were obtained on a matrix‑assisted laser desorption/ionization-time-of-flight MALDI-TOF/TOF mass spectrometer (4800 Proteomics Analyzer, Applied Biosystems, Foster City, CA, USA) in the positive ion reflector mode and obtained in the mass range from 700-4500 Da with 900 laser shots. Glu-Fib was used for internal calibration. A data‑dependent acquisition method was created to select the 16 most intense peaks in each sample spot (considering 2 spots per fraction) for subsequent tandem mass spectrometry (MS/MS) data acquisition, excluding those from the matrix, due to trypsin autolysis or acrylamide peaks. A fragmentation voltage of 2 kV was used throughout the automated runs. The spectra were processed and analyzed by the T2S (v1.0, Matrix Science Ltd, U.K.) and submitted in Mascot software (v.2.1.0.4, Matrix Science Ltd, U.K.) for protein/peptide identification based on MS/MS data using the following criteria: trypsin as enzyme; a maximum of two missed cleavages; mass tolerances of 20 ppm for peptide precursors, mass tolerance of 0.3 Da was set for fragment ions. Protein identifications based on MS/MS data were considered as reliable when the Mascot ion score confidence level for each individual peptide was > 32. The local FDR (False Discovery Rate) was calculated by searching the spectra against SwissProt (Homo sapiens, release date 01052013) decoy (random) database. Quantification was performed using exponentially modified protein abundance index (emPAI) values, which is based on equation 1 [24]: [emPAI=10NobservedNobservable−1], where “N observed” is the number of experimentally observed peptides and “N observable” is the calculated number of observable peptides, for each protein. Normalization to the total number of peptides in the sample was also performed.
The lists of proteins altered by SH-SY5Y-nanofibers interaction, as determined by MS/MS data, were used for gene ontology and pathway enrichment analyses in Panther [25] and Reactome v57 [26,27], respectively. Reactome analysis was performed with the option to include IntAct interactors to increase the analysis background; the Reactome analysis of down-regulated proteins is presented graphically in Figure 3. From these, the statistically significant (p < 0.05) or near significant (p ≈ 0.05) enriched signaling pathways were selected and listed in Table 3. Of note, no statistically significantly enriched signaling pathways were retrieved with the lower number of up-regulated proteins (p > 0.05).
To evaluate the ability of PLLA nanofibers to support cell growth and proliferation, the resazurin viability assay was performed. For that, the properly sterilized and coated squared-shaped PLLA nanofibers were placed on 24-well plates. A total of 5 × 104 SH-SY5Y cells/2 cm2 were subsequently seeded on the nanofibers or directly on the culture plate bottom (“Control”). At the indicated time points (2nd, 5th, 8th and 11th day) cells were incubated for 4 h with fresh medium containing 10% of a 0.1 mg/mL resazurin (Sigma-Aldrich) in PBS (Pierce, Thermo Scientific). Resazurin reduction to resorufin was thereafter measured by spectrophotometry (microplate reader Infinite 200 PRO Tecan, Grupo Taper, Portugal) at 570 nm (resazurin maximum absorbance) and 600 nm (resorufin maximum absorbance). For each day, a final optical density value (O.D.f) was calculated as follows:
ODf=Sample(OD570nmOD600nm)−NegativeControl(OD570nmOD600nm) |
where the negative control is the O.D. of resazurin in the absence of cells.
At the end of the viability assay (11th day) cells were harvested in 1% boiling SDS and subjected to immunoblot analyses as previously described [28]. Briefly, mass-normalized aliquots (using the BCA protein assay kit, Pierce’s, Thermo Scientific) were electrophoresed on a 5-20% gradient SDS-PAGE and transferred onto nitrocellulose membranes. Ponceau S reversible staining was first performed to detect total protein content, membranes further scanned in a GS-800™ Calibrated Densitometer (Bio-Rad) and band intensities quantified (Quantity One densitometry software, Bio-Rad) for subsequent relative total protein loading corrections [29]. For immunoblotting, the following primary antibodies were used diluted in 3% bovine serum albumin (BSA)/in Tris-buffer saline with Tween (TBS-T): pan-antibody to Actin (1:10; Acris); anti-β-Tubulin antibody (1:2000; 2-28-33, Invitrogen); anti-PARP (214/215) cleavage site (1:1000; Millipore), and anti-PARP antibody (1:1000; Thermo Scientific, Fischer Scientific). Horseradish-peroxidase secondary antibodies (1:5000; GE Healthcare) were used for enhanced chemiluminescence (ECL) detection, using homemade or LuminataTM Crescendo (Millipore) ECL solutions. Quantity One densitometry software (Bio-Rad) was then used to quantify the band intensities using Ponceau S lane levels as a loading control.
The effects of the PLLA materials on undifferentiated SH-SY5Y cells morphology and spreading were assessed at the end of the viability assay (11th day). Briefly, cells grown on coverslips or on PLLA platforms were fixed with a 4% paraformaldehyde (PFA) in PBS solution and permeabilized with 0.1% Triton/PBS. Fixed cells were incubated for 20 min in the dark with Alexa Fluor 568 Phalloidin (Invitrogen) (1:50 in 1% BSA/PBS) to stain filamentous actin (F-actin), and mounted with the DAPI-plus Vectashield® (Vector Laboratories) on 0.1 mm microscope glass slides for analysis in an Olympus IX-81 inverted epifluorescence microscope (LCPlanFl 20x/0.40 objective).
The same procedure was applied to analyze the effects of PLLA nanofibers on SH-SY5Y cells cultured for two days with 10 μM Retinoic Acid (RA) in 10% FBS medium, to evaluate the effects of the nanofibers on the onset of neuron-like SH-SY5Y differentiation.
Data is expressed as mean ± SE (standard error) of at least three independent experiments. Statistical significance analysis was conducted by one way analysis of variance (ANOVA) followed by the Tukey’s test (if samples’ SE were statistically different) or Welch’s test (if samples’ SE were non-statistically different).
PLLA scaffolds are piezoelectric biodegradable materials that when electrospun as nanofibers can provide topographic cues known to promote differentiation [2,3]. In this work we explored the cellular responses elicited by PLLA-based nanofibers (“NanoF”) that might underlie their ability to promote neuronal differentiation.
Electrospun NanoF were first characterized by scanning electron microscopy (SEM), and their ability to support SH-SY5Y cells adhesion was further confirmed. NanoF SEM micrographs are presented in Figure 1a. The electrospun fibers-based platforms presented a thickness around 150 µm with nanometer-sized fibers, with an average diameter size of 468 ± 165 nm. Although a lower diameter size (e.g. to 200-300 nm) has shown to improve neuronal differentiation [18] we verified that lowering the PLLA concentration in the solution led to instability of the charged jet during the electrospinning process and subsequently to a mesh with higher heterogeneity of fibers’ sizes. The NanoF platforms also presented some larger fibers, 0.97 ± 0.36 µm of average diameter size, which may result from fibers merging. To assess the influence of NanoF on SH-SY5Y cell adhesion, the number of cells that did not adhere after 2h of culture onto empty plates or onto laminin-coated or uncoated NanoF were quantified. Laminin is an extracellular matrix (ECM) protein known to promote neuronal adhesion and differentiation [22]. Figure 1b presents the percentage of adherent cells and reveals that NanoF, with or without surface modification such as laminin-coating, are able to support SH-SY5Y cell adhesion in the same extend as plastic dishes (Control conditions).
After validating the adhesion of SH-SY5Y cells to NanoF, mass spectrometry was used to assess the effects of NanoF on SH-SY5Y cells’ proteome and corresponding cellular pathways. The hypothesis that NanoF induces alterations in SH-SY5Y cells proteome was already suggested by altered protein profiles in the lysates of cells grown on PLLA platforms, evidenced in total protein staining (Figure 2a). In particular, two bands (at ~60 and 70 kDa) seemed more intense in the lysates of cells grown on the NanoF, whereas other NanoF bands (at ~80 and 100 kDa) were slightly fainter. These exact alterations also occurred in SH-SY5Y lysates of cells grown on other PLLA-based platforms, namely solvent-casted films and electrospun scaffolds with aligned nanofibers (data not shown).
Mass spectrometry analysis of the four extracted bands (60, 70, 80 and 100 kDa; arrowheads in Figure 2a) identified 185 different proteins. From these, only 83 proteins had at least 2 hints in each of the conditions (Control or NanoF). The emPAI was then used as an indicator of protein abundance within the sample, enabling protein classification as “up- or down-regulated”. Of these 83, 38 were found to be equally expressed in Control and NanoF samples, 12 were up-regulated in NanoF conditions (increased in NanoF, when compared to Control, or exclusively found in NanoF), and 33 were down-regulated in NanoF (decreased in NanoF, when compared to Control, or exclusively found in Control samples) (Table 1, Supplementary Table S1).
Band | Identified proteins | Equal emPAIs | Different emPAIs | |||
Upregulated in NanoF | Downregulated in NanoF | |||||
Unique in NanoF | UpR in NanoF | Unique in Control | DownR in NanoF | |||
100 kDa | 29 | 11 | 4 | 2 | 4 | 7 |
80 kDa | 38 | 22 | 3 | 3 | 3 | 6 |
70 kDa | 40 | 17 | 4 | 4 | 2 | 8 |
60 kDa | 27 | 13 | 0 | 2 | 5 | 6 |
Total | 83 | 38 | 6 | 6 | 13 | 20 |
12 | 33 |
The functional processes and pathways in which the identified up- and down-regulated proteins are involved were further explored (Figure 2b). The functional pie charts revealed that cells grown on NanoF shift their protein expression towards a more plastic differentiation-supportive state, contrary to the more proliferative-state observed in Control cells. Up-regulated proteins in cells grown on NanoF are mainly involved in cellular pathways that play a role in cell metabolism, protein trafficking, cytoskeleton assembly and remodeling, and in ECM stabilization. Proteins that are down-regulated by NanoF are mostly involved in pathways underlying cell division and DNA replication, DNA expression and protein synthesis, cell metabolism, DNA repair and stress response.
Identified proteins: the number of proteins identified in each gel band of indicated molecular weight (kDa). These proteins were classified as: “Unique”, proteins found in all samples of only one of the conditions (Control or NanoF); “UpR”, upregulated proteins, proteins whose emPAI value is higher in duplicates or triplicates of the NanoF condition in comparison with the duplicates or triplicates of the Control condition. “DownR”, downregulated proteins, NanoF proteins with an emPAI value lower than the Control condition. Protein expression was considered altered if the Mascot score > 32 and the protein was identified in at least two samples of the same condition (Control or NanoF).
Table 2 describes the ID and the function of relevant proteins found altered by NanoF by the mass spectrometry analysis, also relating them to Figure 2b. Up-regulated proteins in SH-SY5Y cells grown on NanoF include proteins involved in cell metabolism, in agreement with most recent findings that PLLA nanofibers increase the cellular energetic metabolism [20]. Further, three interesting proteins involved in neural development, cell-cell adhesion (and cell proliferation inhibition) and actin remodeling were also up-regulated by NanoF. Alpha-2-HS-glycoprotein (alias Fetuin) is secreted by stem cell-derived skin lineage precursors and participates in endocytosis and in extracellular matrix formation [30], being involved in bone and brain development [31]. Inter-alpha-trypsin inhibitor heavy chain H2 is a protein that bridges hyaluronan and other matrix proteins, and was observed to block glioma cells invasion, inhibit their proliferation and to promote cell-cell adhesion, partially via the phosphatidylinositol 3-kinase/Akt signaling cascade [32]. Gelsolin, found three-fold increased, has a major role in actin remodeling as it induces the nucleation of actin monomers to form new actin filaments, and the severing of already formed filaments [33,34].
Accession number | Protein name | Molecular weight1 | Fold increase | Cellular function | Ref. |
P06396 | Gelsolin | 87 kDa | 3.27* | Cytoskeleton assembly and remodeling | [33,34] |
GELS_HUMAN | (nucleation of actin monomers into filaments and severing of already formed filaments) | ||||
P02765 | Alpha-2-HS-glycoprotein | 39 kDa | 1.52 | ECM stabilization | [30,31] |
FETUA_HUMAN | (extracellular matrix maturation,brain development,endocytosis) | ||||
P19823 | Inter-alpha-trypsin inhibitor heavy chain H2 | 106 kDa | 1.75 | ECM stabilization | [32] |
ITIH2_HUMAN | (intermediate protein between hyaluronan and other matrix protein; inhibitor of neural cells proliferation and inducer of cell-cell adhesion) | ||||
P17844 | Probable ATP-dependent RNA helicase DDX5 | 69 kDa | 0.33 | Protein synthesis | [39] |
DDX5_HUMAN | (involved in the alternative regulation of pre-mRNA splicing) | ||||
Q16643 DREB_HUMAN | Drebrin | 71 kDa | 0.31* | Cytoskeleton assembly and remodeling | [47] |
(required for actin polymerization,cell migration and neuronal plasticity | |||||
Q14195 | Dihydropyrimidinase-related protein 3 | 62 kDa | 0.46 | Cytoskeleton assembly and remodeling | [63] |
DPYL3_HUMAN | (regulation of neuronal growth cone collapse via semaphorins signaling) | ||||
P11021 | 78 kDa glucose-regulated protein | 72 kDa | 0.46 | Protein folding | [41,42] |
GRP78_HUMAN | (ER chaperon; assembly of multimeric protein complexes) | ||||
P08238 | Heat shock protein HSP 90-beta | 83 kDa | 0.41 | Cell proliferation (also protein folding) | [41] |
HS90B_HUMAN | (regulation of proteins involved in cell cycle and signal transduction; chaperon) | ||||
P02545 LMNA_HUMAN | Prelamin-A/C | 74 kDa | 0.32* | DNA replication | [37,38] |
(nuclear assembly and chromatin organization) | |||||
P09874 PARP1_HUMAN | Poly [ADP-ribose] polymerase 1 | 113 kDa | 0,36 | DNA repair | [43,44] |
(reparation of DNA strand breaks and transcription regulator) | |||||
Q00839 HNRPU_HUMAN | Heterogeneous nuclear ribonucleoprotein U | 91 kDa | 0.61 | Protein synthesis | [40] |
(pre-mRNA processing,mRNA metabolism and transport) | |||||
Q07666 KHDR1_HUMAN | KH domain-containing,RNA-binding,signal transduction-associated protein 1 | 48 kDa | 0.50 | Cell proliferation | [35] |
(role in G2-M progression in cell cycle) | |||||
P33992 MCM5_HUMAN | DNA replication licensing factor MCM5 | 82 kDa | 0.57 | DNA replication | [36] |
(component of the MCM complex,a putative replicative helicase,function in DNA replication initiation and elongation) | |||||
P35241 RADI_HUMAN | Radixin | 69 kDa | 0.64 | Cytoskeleton assembly and remodeling | [48] |
(member of the ERM actin regulator proteins. Anchorage of the plasma membrane and the actin cytoskeleton) | |||||
Q13263 TIF1B_HUMAN | Transcription intermediary factor 1-beta | 89 kDa | 0.23 | Protein synthesis | [45,46] |
(regulator of DNA transcription) | |||||
The main proteins whose levels were found altered in cells grown for 11 days on PLLA nanofibers and identified in at least 2 samples of each condition (Control or NanoF) are listed. The Fold Increase (FI) was calculated based on the emPAI, indicator of the protein abundance in the sample; positive FI: up-regulated protein in cells grown on NanoF; negative FI: down-regulated protein in cells grown on NanoF. Asterisk (*) indicates statistical significance (p < 0, 05) of the fold increase; the majority of the proteins is only tendentiously up- or down-regulated. The function of the identified proteins is based on information contained in the indicated references (Ref.). 1Protein molecular weight without considering post-translational modifications. |
Regarding the down-regulated proteins, a major part is involved in chromatin organization, DNA replication and repair, and gene expression. These include KHDR1, a regulator of the cell cycle progression [35]; MCM5, a putative helicase involved in DNA replication facilitation [36]; and Prelamin-A/C, which participates in nuclear assembly and structural maintenance, and in chromatin organization [37,38]. Two proteins involved in pre-mRNA metabolism are also down-regulated: Heterogeneous nuclear ribonucleoprotein U (HNRPU) and a putative RNA helicase (DDX5), potentially involved in the regulation of pre-mRNA splicing [39,40].
NanoF also down-regulated stress-related chaperones such as HSP90 and GRP78 [41]. The later is also involved in the regulation of the cell cycle and apoptosis [42], as the DNA stress-induced Poly (ADP-ribose) polymerase 1 (PARP1) protein, involved in DNA strand reparation and regulation of DNA transcription [43,44]. Like PARP1 (3-fold decreased), the Transcription intermediary factor 1-beta (TIF1B) [45,46] is also downregulated (4-fold decreased).
Other proteins involved in cytoskeleton polymerization and stabilization, and neuronal growth cone collapse, were also decreased (Table 2). Drebrin (DREB), for instance, is involved in actin polymerization and neuronal plasticity [47]; Radixin (RADI) is a member of the Ezrin-Radixin-Moesin (ERM) actin regulators, well-known to regulate actin polymerization. ERM are a class of highly homologous proteins that structurally and functionally link the plasma membrane to the cortical F-actin cytoskeleton [48]. The also decreased Dihydropyrimidinase-related protein 3 (DPYL3) is involved in the semaphorins signaling for neuronal growth cone collapse.
Various signaling pathways were also found hindered by NanoF exposure when the interaction network of the downregulated proteins was expanded using the Reactome software. Figure 3 shows near the same cellular processes as the ones obtained with the Panther software (Figure 2b), plus various signaling pathways. From these, enriched signaling pathways (p < or ≈ 0.05) were selected and listed in Table 3. Concordantly with the functional analyses of main altered proteins, the majority of the pathways is involved in cell proliferation, being related to growth factors and their receptors (Table 2). These comprise the Vascular endothelial growth factor (VEGF) [49], the Fibroblast growth factor receptors 1 and 2 (FGFR1 and FGFR2) [50], the Epidermal growth factor receptor (EGFR) [51], and the EGFR-interactor and regulator Protein-tyrosine kinase 6 (PTK6, alias Brk) [52]. Two other pathways, related to cellular stress (NLR signaling pathway) and growth cone collapse, were also inhibited by NanoF. Central to the first pathway are the Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) and many of its family members. These are involved in inflammasome complexes in human cells in response to stress and may induce caspase activation [54]. The second one, the Sem3A semaphorin signaling, is a known pathway that mediates the collapse of the growth cones at the tips of growing neurites in differentiating and regenerating neurons [54].
The SH-SY5Y down-regulated proteins (“submitted entities”) identified in the MS/MS data were analysed using the bioinformatics tool Reactome upon extending their network of interactors. Significantly enriched (p < 0.05) signaling pathways are listed here. “Entities found”: the curated and interacting molecules that are common between the submitted data set and the pathway named. “Submitted entities hit interactor” (interactors found): IntAct-interacting molecules that are common between the submitted data set and the pathway named. “Interacts with”: other interacting molecules that are not listed in the submitted data set.
The mass spectrometry data suggested that NanoF induced a decrease in SH-SY5Y cells proliferation. The influence of the PLLA platforms on the number of SH-SY5Y cells with time in culture was assessed via the non-destructive metabolic Resazurin assay (Figure 4a). Uncoated and laminin-coated PLLA platforms were evaluated. An effect of inhibition of neuroblastoma cell number was confirmed to exist for the NanoF condition. A decrease in cells proliferation is evident from the proliferation curves of SH-SY5Y cells grown on NanoF (Figure 4a). This is concordant with all functional analyses of the MS/MS proteomic results, including the findings that cell proliferation signaling pathways such as the VEGF, FGFR, and EGFR, were inhibited (Table 3). Laminin-coating similarly decreased cell proliferation (Figure 4a), as expected since laminin is an ECM protein that influences cellular processes including survival, proliferation and differentiation [22]. NanoF may similarly influence these processes as it mimics the ECM nanoarchitecture [55].
Pathway name | Entities pValue | Entities FDR | Submitted entities found | Submitted entities hit interactor | Interacts with |
Signaling by VEGF | 0.0018 | 0.0106 | HS90A_HUMAN | HS90B_HUMAN;KHDR1_HUMAN;U5S1_HUMAN;GRP78_HUMAN;HS90A_HUMAN;HSP71_HUMAN;HSP7C_HUMAN | P04049;P07900;P35916;P31749;P19174;P53041;P06241;P15056;P04792 |
Signaling by PTK6 | 0.0074 | 0.0252 | KHDR1_HUMAN | HS90B_HUMAN;KHDR1_HUMAN;GRP78_HUMAN;HS90A_HUMAN;HSP7C_HUMAN | Q5S007;P31749;Q07666 |
CRMPs in Sema3A signaling | 0.0088 | 0.0265 | DPYL2_HUMAN;DPYL3_HUMAN | - | - |
Cytokine Signaling in Immune system | 0.0316 | 0.0537 | NUP93_HUMAN | MCM7_HUMAN;HS90B_HUMAN;KHDR1_HUMAN;KINH_HUMAN;GRP78_HUMAN;HS90A_HUMAN;LMNA_HUMAN | P04049;Q99558;P15498;P41279;P19838;P07948;P53041;P15056;P63104 |
Signaling by Ligand-Responsive EGFR Variants in Cancer | 0.0353 | 0.0537 | HS90A_HUMAN | KHDR1_HUMAN | P19174 |
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 0.0353 | 0.0537 | HS90A_HUMAN | KHDR1_HUMAN | P19174 |
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | 0.0354 | 0.0537 | HS90B_HUMAN | MCM7_HUMAN;HS90B_HUMAN;HS90A_HUMAN | Q9Y6K9;P08238;Q9Y239 |
Signal Transduction | 0.0547 | 0.0547 | HNRPM_HUMAN; PARP1_HUMAN; | MCM7_HUMAN;HS90B_HUMAN;PARP1_HUMAN;HS90A_HUMAN;SF3A1_HUMAN;LMNA_HUMAN;GANAB_HUMAN;TIF1B_HUMAN;KHDR1_HUMAN;DDX5_HUMAN;U5S1_HUMAN;HNRPU_HUMAN;KINH_HUMAN;GRP78_HUMAN;HSP71_HUMAN;HSP7C_HUMAN;NUP93_HUMAN | P04049;Q13546;Q13547;P05412;P49674;P31749;O15111;P31946;Q07666;P06241;P09874;P09651;P08047;Q01974;P15498;Q9UNE7;P46527;Q12933;P36896;P15056;Q09472;P07900;P35916;Q5S007;P19174;P00533;Q15831;P01106;Q13573;P63104;P04792;P42679;P53041;P32121;P31152 |
KHDR1_HUMAN; | |||||
KINH_HUMAN; | |||||
HS90A_HUMAN | |||||
Signaling by FGFR2 | 0.0561 | 0.0561 | HNRPM_HUMAN | HS90B_HUMAN;KHDR1_HUMAN;GRP78_HUMAN;HS90A_HUMAN | P04049;P31749;O15111;P19174;P53041;P15056;P09651 |
Signaling by FGFR | 0.0579 | 0.0579 | HNRPM_HUMAN | HS90B_HUMAN;KHDR1_HUMAN;GRP78_HUMAN;HS90A_HUMAN | P04049;P31749;O15111;P19174;P53041;P15056;P09651 |
According to the MS/MS data, one of the proteins whose levels were highly decreased by NanoF is PARP1 (Table 2). PARP (117 KDa) is a crucial protein regulating the cell cycle and DNA repair, which is cleaved by caspase 3 and 7 during apoptosis, yielding two fragments of 85 and 25 kDa [43,44]. The MS/MS analysis of the 80 kDa band suggests that PARP and/or its cleavage ~85 kDa fragment are decreased in NanoF-cultured cells. Full-length PARP is more indicative of cell division and DNA repair, while the ratio between PARP cleaved and full-length forms is an indirect measure of apoptosis. The levels of full length PARP1 (117 KDa) and of its apoptosis-induced cleaved fragment were measured (Figure 4b). Cells cultured on NanoF presented a consistently decreased ratio of PARP cleavage into the 85 kDa fragment (Figure 4b, cleaved/full length PARP ratio), either in uncoated or in laminin-coated NanoF. Laminin-coated NanoF always presented the lowest values of full-length and cleaved PARP, in what appears a synergistic action of the nanofibers’ topography and the ECM coating. These results first confirm the PARP1 data from the MS/MS proteomic analysis (Table 2) and suggest lower cellular apoptosis for cells grown on NanoF. Furthermore, it confirms that the previously observed decreases in cell density (Figure 4a) are not due to increased apoptosis but rather to lower cell proliferation, as already suggested by the bioinformatics functional analyses to the MS/MS data (Figures 2b and 3,Tables 2 and 3).
Growth characteristics of neurites (as number, morphology, orientation and rate) are determined by environmental cues and cellular mechanisms that involve altered actin and tubulin cytoskeletons dynamics [56]. Actin mediates the establishment of cellular morphology and the interaction with the ECM [57]. Tubulin, less subject to turnover, provides a scaffold for maintaining the extending neurite [57]. Besides inhibition of cell proliferation, NanoF upregulated proteins are also involved in cytoskeleton remodeling, protein trafficking, and cell-cell adhesion. The proteome seems to shift to enable cells to undergo significant morphological alterations that may prepare them for the onset of cellular differentiation [58].
To first evaluate the effects of NanoF on the cytoskeleton and on cells differentiation, the levels of cytoskeleton-related proteins, i.e. actin and tubulin, were assessed (Figure 5a). Actin and tubulin levels were found to decrease in cells grown on NanoF, and accentuated when the platforms were laminin-coated. Subsequently, the morphology of SH-SY5Y cells cultured on NanoF was monitored in non-differentiating conditions (Figure 5b, left panel). The previously observed variations in cell number (Figure 4a) are roughly visually confirmed in the fluorescence images, as NanoF presents a decreased cell number (Figure 5b). In these non-differentiating conditions (left panel), NanoF induced alterations in cell distribution, shape and cytoskeleton rearrangements. NanoF samples increase cell-cell adhesion and alter the cuboid morphology of cells (observed in control conditions) to a round-shaped one. Additionally, NanoF appear to induce the depolymerisation of the filamentous actin (F-actin) in stress fibers, which are the linear arrays of actin bundles that cross the cells (visible in Control cells) (Figure 5b, left panel). Hence, in the absence of differentiating inductors, cells grown on the PLLA nanofibers present an accentuated decrease on actin levels and acquire a rounder morphology with few or no visible stress fibers due to F-actin disruption (Figure 5a, b left panel). Poor spreading in nanofibrous scaffold has been observed in other cell types such as the endothelial cells (HUVECs) [59], and may relate to the NanoF high hydrophobicity (data to be submitted elsewhere). Indeed, hydrophobicity inhibits the formation of mature focal adhesions (FA) and delays cytoskeleton development [60]. Further, NanoF induced the up-regulation of the Inter-alpha-trypsin inhibitor heavy chain H2, which increases cell-cell adhesion [32]. The NanoF-induced disruption of the actin cytoskeleton might be mediated by the down-regulation of actin polymerizing proteins such as Radixin and Drebrin, and the up-regulation of the F-actin remodeling protein, Gelsolin. This calcium-regulated protein severs pre-existing F-actin filaments and caps their growing barbed ends [34]. Gelsolin might be activated by calcium influxes arising from the cells adhesion and adaptation to the nanofibers’ surface and subsequent activation of stretch-activated cation channels; these transduce mechanical signals from FAs to the cytoskeleton, that ultimately lead to actin reorganization [61].
Actin remodeling is a known necessary step for cells to acquire a specialized morphology upon differentiation. Moreover, we have previously observed that an early period of drop on tubulin and actin levels occur at the onset of SH-SY5Y neuronal differentiation [21]. We thus hypothesize that the NanoF-induced actin remodeling render cells in a transmorphogenic state [62] that make them more prone to respond to differentiating drugs such as Retinoic acid (RA) (Figure 5c). Concordantly, SH-SY5Y cells grown on NanoF in the presence of RA present a more neuron-like morphology, as these extend a higher number of longer projections than control cells already at 2 days in RA (Figure 5b, right panel). Hence, cells grown on NanoF present an altered morphology and cytoskeleton and are more prone to undergo neuronal differentiation, most possibly due to the intrinsic changes in their
proteome that starts to shift towards a morphological and functional state more responsive to differentiation [21,58]. Accordingly, the proteomic data above indicates that these cells have already initiated some of the differentiating events induced by morphogens as RA, such as signaling for hindering cell division and the induction of cytoskeleton remodeling [21].
PLLA-based materials have been studied as promising tools for regenerative medicine approaches. Nanofibrous scaffolds have been particularly explored due to their topographical cues that resemble the natural ECM. In this study, we have further explored the cellular responses induced by the interaction between PLLA-based nanofibers and SH-SY5Y cells. Our analyses reveal that PLLA nanofibrous platforms induce a reorganization of the SH-SY5Y cells proteome and differentially activate and inhibit specific cellular functions and signaling pathways. These include blocking cellular proliferation and facilitating cells morphological remodeling and adaptation to the substrate, rendering cells in a more responsive state what ultimately facilitates the onset of cellular differentiation. This knowledge of the cellular behavior on biomaterials is of key importance for the development and optimization of scaffolds that potentiate the regeneration of injured tissues. In the light of the piezoelectric character of PLLA, our group is currently focused on exploiting electrically-induced PLLA polarization and piezoelectricity to deliver further optimized neuritogenic scaffolds.
This work was supported by Fundação para a Ciência e a Tecnologia (FCT), Fundo Europeu de Desenvolvimento Regional Portugal (FEDER), QREN-COMPETE Portugal: project PTDC/SAU-NMC/111980/2009, scholarship FRH/BD/47331/2008, Institute for Biomedicine iBiMED UID/BIM/04501/2013, Centre for Cell Biology CBC Pest-OE/SAU/UI0482/2014, Associate Laboratory CICECO (PEst-C/CTM/LA0011/2013), QOPNA research unit (PEst-C/QUI/UI0062/2013), and RNEM (Portuguese Mass Spectrometry Network).
All authors declare no conflicts of interest in this paper
Proteins Upregulated in NanoF | Proteins Downregulated in NanoF | ||
Unique in NanoF | UpR in NanoF | Unique in Control | DownR in NanoF |
Alpha-2-macroglobulin | Serum albumin | Aminopeptidase B | ATP-citrate synthase |
Complement C3 | Alpha-fetoprotein | Cytoskeleton-associated protein 4 | Probable ATP-dependent RNA helicase DDX5 |
Hemoglobin subunit alpha | Alpha-2-HS-glycoprotein | Cytoplasmic dynein 1 intermediate chain 2 | Drebrin |
Hemoglobin subunit beta | Gelsolin | Dipeptidyl peptidase 3 | Dihydropyrimidinase-related protein 3 |
Inter-alpha-trypsin inhibitor heavy chain H4 | Inter-alpha-trypsin inhibitor heavy chain H2 | Dihydropyrimidinase-related protein 2 | 78 kDa glucose-regulated protein |
DNA repair and recombination protein RAD54-like | Septin-9 | Neutral alpha-glucosidase AB | Heat shock protein HSP 90-alpha |
Ras GTPase-activating protein-binding protein 2 | Heat shock protein HSP 90-beta | ||
Kinesin-1 heavy chain | Heat shock 70 kDa protein 1A/1B | ||
DNA replication licensing factor MCM7 | Heat shock cognate 71 kDa protein | ||
Nuclear pore complex protein Nup93 | Interleukin enhancer-binding factor 3 | ||
U4/U6 small nuclear ribonucleoprotein Prp3 | Mitochondrial inner membrane protein | ||
Splicing factor 3A subunit 1 | Prelamin-A/C | ||
116 kDa U5 small nuclear ribonucleoprotein component | Poly [ADP-ribose] polymerase 1 | ||
Heterogeneous nuclear ribonucleoprotein U | |||
Heterogeneous nuclear ribonucleoprotein M | |||
KH domain-containing, RNA-binding, signal transduction-associated protein 1 | |||
DNA replication licensing factor MCM5 | |||
Radixin | |||
Lysosome membrane protein 2 | |||
Transcription intermediary factor 1-beta |
[1] |
Seil JT, Webster TJ (2010) Electrically active nanomaterials as improved neural tissue regeneration scaffolds. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2: 635-647. doi: 10.1002/wnan.109
![]() |
[2] | Quan Q, Chang B, Meng HY, et al. (2016) Use of electrospinning to construct biomaterials for peripheral nerve regeneration. Rev Neurosci.27: 761-768 |
[3] |
Tian L, Prabhakaran MP, Ramakrishna S (2015) Strategies for regeneration of components of nervous system: scaffolds, cells and biomolecules. Regen Biomater 2: 31-45. doi: 10.1093/rb/rbu017
![]() |
[4] |
Yang F, Murugan R, Wang S, et al. (2005) Electrospinning of nano/micro scale poly(L-lactic acid) aligned fibers and their potential in neural tissue engineering. Biomaterials 26: 2603-2610. doi: 10.1016/j.biomaterials.2004.06.051
![]() |
[5] |
Wang HB, Mullins ME, Cregg JM, et al. (2009) Creation of highly aligned electrospun poly-L-lactic acid fibers for nerve regeneration applications. J Neural Eng 6: 016001. doi: 10.1088/1741-2560/6/1/016001
![]() |
[6] |
Morelli S, Salerno S, Piscioneri A, et al. (2010) Influence of micro-patterned PLLA membranes on outgrowth and orientation of hippocampal neurites. Biomaterials 31: 7000-7011. doi: 10.1016/j.biomaterials.2010.05.079
![]() |
[7] |
Callahan LA, Xie S, Barker IA, et al. (2013) Directed differentiation and neurite extension of mouse embryonic stem cell on aligned poly(lactide) nanofibers functionalized with YIGSR peptide. Biomaterials 34: 9089-9095. doi: 10.1016/j.biomaterials.2013.08.028
![]() |
[8] |
Borgens RB (1999) Electrically mediated regeneration and guidance of adult mammalian spinal axons into polymeric channels. Neuroscience 91: 251-264. doi: 10.1016/S0306-4522(98)00584-3
![]() |
[9] |
Ding Y, Yan Q, Ruan JW, et al. (2009) Electro-acupuncture promotes survival, differentiation of the bone marrow mesenchymal stem cells as well as functional recovery in the spinal cord-transected rats. BMC Neurosci 10: 35. doi: 10.1186/1471-2202-10-35
![]() |
[10] |
Guo B, Finne-Wistrand A, Albertsson AC (2010) Molecular architecture of electroactive and biodegradable copolymers composed of polylactide and carboxyl-capped aniline trimer. Biomacromolecules 11: 855-863. doi: 10.1021/bm9011248
![]() |
[11] |
Yang F, Murugan R, Ramakrishna S, et al. (2004) Fabrication of nano-structured porous PLLA scaffold intended for nerve tissue engineering. Biomaterials 25: 1891-1900. doi: 10.1016/j.biomaterials.2003.08.062
![]() |
[12] | Yang IH, Co CC, Ho CC (2011) Controlling neurite outgrowth with patterned substrates. J Biomed Mater Res A 97: 451-456. |
[13] |
Lee YS, Collins G, Arinzeh TL (2011) Neurite extension of primary neurons on electrospun piezoelectric scaffolds. Acta Biomater 7: 3877-3886. doi: 10.1016/j.actbio.2011.07.013
![]() |
[14] |
Lee YS, Arinzeh TL (2012) The influence of piezoelectric scaffolds on neural differentiation of human neural stem/progenitor cells. Tissue Eng Part A 18: 2063-2072. doi: 10.1089/ten.tea.2011.0540
![]() |
[15] | He L, Liao S, Quan D, Ma K, et al. (2010) Synergistic effects of electrospun PLLA fiber dimension and pattern on neonatal mouse cerebellum C17.2 stem cells. Acta Biomaterialia 6: 2960-2969. |
[16] |
Fukada E (2000) History and recent progress in piezoelectric polymers. IEEE Trans Ultrason Ferroelectr Freq Control 47: 1277-1290. doi: 10.1109/58.883516
![]() |
[17] |
Corey JM, Gertz CC, Wang BS, et al. (2008) The design of electrospun PLLA nanofiber scaffolds compatible with serum-free growth of primary motor and sensory neurons. Acta Biomater 4: 863-8675. doi: 10.1016/j.actbio.2008.02.020
![]() |
[18] |
He L, Liao S, Quan D, et al. (2010) Synergistic effects of electrospun PLLA fiber dimension and pattern on neonatal mouse cerebellum C17.2 stem cells. Acta Biomater 6: 2960-2969. doi: 10.1016/j.actbio.2010.02.039
![]() |
[19] |
Evans GR, Brandt K, Widmer MS, et al. (1999) In vivo evaluation of poly(L-lactic acid) porous conduits for peripheral nerve regeneration. Biomaterials 20: 1109-1115. doi: 10.1016/S0142-9612(99)00010-1
![]() |
[20] |
Yu Y, Meng D, Man L, et al. (2016) The Interactions Between Aligned Poly(L-Lactic Acid) Nanofibers and SH-SY5Y Cells In Vitro. J Nanosci Nanotechnol 16: 6407-6413. doi: 10.1166/jnn.2016.10883
![]() |
[21] | da Rocha JF, da Cruz e Silva OA, Vieira SI (2015) Analysis of the amyloid precursor protein role in neuritogenesis reveals a biphasic SH-SY5Y neuronal cell differentiation model. J Neurochem 134: 288-301. |
[22] |
Koh HS, Yong T, Chan CK, et al. (2008) Enhancement of neurite outgrowth using nano-structured scaffolds coupled with laminin. Biomaterials 29: 3574-3582. doi: 10.1016/j.biomaterials.2008.05.014
![]() |
[23] | Pina S, Vieira SI, Rego P, et al. (2010) Biological responses of brushite-forming Zn- and ZnSr- substituted beta-tricalcium phosphate bone cements. Eur Cell Mater 20: 162-177. |
[24] |
Ishihama Y, Oda Y, Tabata T, et al. (2005) Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 4: 1265-1272. doi: 10.1074/mcp.M500061-MCP200
![]() |
[25] |
Mi H, Thomas P (2009) PANTHER pathway: an ontology-based pathway database coupled with data analysis tools. Methods Mol Biol 563: 123-140. doi: 10.1007/978-1-60761-175-2_7
![]() |
[26] |
Milacic M, Haw R, Rothfels K, et al. (2012) Annotating cancer variants and anti-cancer therapeutics in reactome. Cancers (Basel) 4: 1180-1211. doi: 10.3390/cancers4041180
![]() |
[27] |
Fabregat A, Sidiropoulos K, Garapati P, et al. (2016) The Reactome pathway Knowledgebase. Nucleic Acids Res 44: D481-D487. doi: 10.1093/nar/gkv1351
![]() |
[28] |
Henriques AG, Vieira SI, Crespo-López ME, et al. (2009) Intracellular sAPP retention in response to Abeta is mapped to cytoskeleton-associated structures. J Neurosci Res 87: 1449-1461. doi: 10.1002/jnr.21959
![]() |
[29] |
Romero-Calvo I, Ocón B, Martínez-Moya P, et al. (2010) Reversible Ponceau staining as a loading control alternative to actin in Western blots. Anal Biochem 401: 318-320. doi: 10.1016/j.ab.2010.02.036
![]() |
[30] | Nistor G, Poole AJ, Draelos Z, et al. (2016) Human Stem Cell-Derived Skin Progenitors Produce Alpha 2-HS Glycoprotein (Fetuin): A Revolutionary Cosmetic Ingredient. J Drugs Dermatol 15: 583-598. |
[31] |
Elsas J, Sellhaus B, Herrmann M, et al. (2013) Fetuin-a in the developing brain. Dev Neurobiol 73: 354-369. doi: 10.1002/dneu.22064
![]() |
[32] |
Werbowetski-Ogilvie TE, Agar NY, Waldkircher de Oliveira RM, et al. (2006) Isolation of a natural inhibitor of human malignant glial cell invasion: inter alpha-trypsin inhibitor heavy chain 2. Cancer Res 66: 1464-1472. doi: 10.1158/0008-5472.CAN-05-1913
![]() |
[33] |
Ono S (2007) Mechanism of depolymerization and severing of actin filaments and its significance in cytoskeletal dynamics. Int Rev Cytol 258: 1-82. doi: 10.1016/S0074-7696(07)58001-0
![]() |
[34] |
Shekhar S, Pernier J, Carlier MF (2016) Regulators of actin filament barbed ends at a glance. J Cell Sci 129: 1085-1091. doi: 10.1242/jcs.179994
![]() |
[35] | Barlat I, Maurier F, Duchesne M, et al. (1997) A role for Sam68 in cell cycle progression antagonized by a spliced variant within the KH domain. J Biol Chem 272: 3129-3132. |
[36] | Tsuji T, Ficarro SB, Jiang W (2006) Essential role of phosphorylation of MCM2 by Cdc7/Dbf4 in the initiation of DNA replication in mammalian cells. Mol Biol Cell 17: 4459-4472. |
[37] | De Vos WH, Houben F, Hoebe RA, et al. (2010) Increased plasticity of the nuclear envelope and hypermobility of telomeres due to the loss of A-type lamins. Biochim Biophys Acta 1800: 448-458. |
[38] | Nardella M, Guglielmi L, Musa C, et al. (2015) Down-regulation of the Lamin A/C in neuroblastoma triggers the expansion of tumor initiating cells. Oncotarget 6: 32821-32840. |
[39] |
Jurica MS, Licklider LJ, Gygi SR, et al. (2002) Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis. RNA 8: 426-439. doi: 10.1017/S1355838202021088
![]() |
[40] | Weidensdorfer D, Stöhr N, Baude A, et al. (2009) Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs. RNA 15: 104-115. |
[41] |
Nami B, Ghasemi-Dizgah A, Vaseghi A (2016) Overexpression of molecular chaperons GRP78 and GRP94 in CD44(hi)/CD24(lo) breast cancer stem cells. Bioimpacts 6: 105-110. doi: 10.15171/bi.2016.15
![]() |
[42] | Zhou H, Zhang Y, Fu Y, et al. (2011) Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78): endocrine resistance factor in breast cancer, through release of B-cell lymphoma 2 (BCL-2) from BCL-2-interacting killer (BIK). J Biol Chem 286: 25687-25696. |
[43] | Boulares AH, Yakovlev AG, Ivanova V, et al. (1999) Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis: Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem 274: 22932-22940. |
[44] |
Ahel I, Ahel D, Matsusaka T, et al. (2008) Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins. Nature 451: 81-85. doi: 10.1038/nature06420
![]() |
[45] |
Moosmann P, Georgiev O, Le Douarin B, et al. (1996) Transcriptional repression by RING finger protein TIF1 beta that interacts with the KRAB repressor domain of KOX1. Nucleic Acids Res 24: 4859-48567. doi: 10.1093/nar/24.24.4859
![]() |
[46] |
Riclet R, Chendeb M, Vonesch JL, et al. (2009) Disruption of the interaction between transcriptional intermediary factor 1{beta} and heterochromatin protein 1 leads to a switch from DNA hyper- to hypomethylation and H3K9 to H3K27 trimethylation on the MEST promoter correlating with gene reactivation. Mol Biol Cell 20: 296-305. doi: 10.1091/mbc.E08-05-0510
![]() |
[47] | Shim KS, Lubec G. Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome. Neurosci Lett 324: 209-212. |
[48] |
Ponuwei GA (2016) A glimpse of the ERM proteins. J Biomed Sci 23: 35. doi: 10.1186/s12929-016-0246-3
![]() |
[49] | Liu CX, Xu X, Chen XL, et al. (2015) Glutamate promotes neural stem cell proliferation by increasing the expression of vascular endothelial growth factor of astrocytes in vitro. Cell Mol Biol 61: 75-84. |
[50] |
Semrad TJ, Mack PC (2012) Fibroblast growth factor signaling in non-small-cell lung cancer. Clin Lung Cancer 13: 90-95. doi: 10.1016/j.cllc.2011.08.001
![]() |
[51] | Yano S, Kondo K, Yamaguchi M, et al. (2003) Distribution and function of EGFR in human tissue and the effect of EGFR tyrosine kinase inhibition. Anticancer Res 23: 3639-3650. |
[52] |
Mizuguchi Y, Specht S, Isse K, et al. (2015) Breast tumor kinase/protein tyrosine kinase 6 (Brk/PTK6) activity in normal and neoplastic biliary epithelia. J Hepatol 63: 399-407. doi: 10.1016/j.jhep.2015.02.047
![]() |
[53] |
Lee S, Suh GY, Ryter SW, et al. (2016) Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease. Am J Respir Cell Mol Biol 54: 151-160. doi: 10.1165/rcmb.2015-0231TR
![]() |
[54] | Goshima Y, Yamashita N, Nakamura F, et al. (2016) Regulation of dendritic development by Semaphorin 3A through novel intracellular remote signaling. Cell Adh Migr 8: 1-14. |
[55] |
Mo XM, Xu CY, Kotaki M, et al. (2004) Electrospun P(LLA-CL) nanofiber: a biomimetic extracellular matrix for smooth muscle cell and endothelial cell proliferation. Biomaterials 25: 1883-1890. doi: 10.1016/j.biomaterials.2003.08.042
![]() |
[56] |
da Silva JS, Dotti CG (2002) Breaking the neuronal sphere: regulation of the actin cytoskeleton in neuritogenesis. Nat Rev Neurosci 3: 694-704. doi: 10.1038/nrn918
![]() |
[57] | Siegel G, Agranoff B, Albers R, et al. (1999) Basic Neurochemistry: Molecular, Cellular and Medical Aspects 6 ed. Philadelphia: Lippincott-Raven. |
[58] | Estefanía MM, Ganier O, Hernández P, et al. (2012) DNA replication fading as proliferating cells advance in their commitment to terminal differentiation. Sci Rep 2: 279. |
[59] |
Tzoneva R, Faucheux N, Groth T (2007) Wettability of substrata controls cell-substrate and cell-cell adhesions. Biochim Biophys Acta 1770: 1538-1547. doi: 10.1016/j.bbagen.2007.07.008
![]() |
[60] | Alves NM, Shi J, Oramas E, et al. (2009) Bioinspired superhydrophobic poly(L-lactic acid) surfaces control bone marrow derived cells adhesion and proliferation. J Biomed Mater Res A 91: 480-488. |
[61] |
Titushkin I, Cho M (2009) Regulation of cell cytoskeleton and membrane mechanics by electric field: role of linker proteins. Biophys J 96: 717-728. doi: 10.1016/j.bpj.2008.09.035
![]() |
[62] | Wen X, Tresco PA (2006) Effect of filament diameter and extracellular matrix molecule precoating on neurite outgrowth and Schwann cell behavior on multifilament entubulation bridging device in vitro. J Biomed Mater Res A 76: 626-637. |
[63] | Weitzdoerfer R, Fountoulakis M, Lubec G (2001) Aberrant expression of dihydropyrimidinase related proteins-2,-3 and -4 in fetal Down syndrome brain. J Neural Transm Suppl 61: 95-107. |
1. | Sara Metwally, Urszula Stachewicz, Surface potential and charges impact on cell responses on biomaterials interfaces for medical applications, 2019, 104, 09284931, 109883, 10.1016/j.msec.2019.109883 | |
2. | Rita Araújo, Tatiana J. Carneiro, Paula Marinho, Marisa Maltez da Costa, Ana Roque, Odete A. B. da Cruz e Silva, Maria Helena Fernandes, Paula M. Vilarinho, Ana M. Gil, NMR metabolomics to study the metabolic response of human osteoblasts to non-poled and poled poly (L-lactic) acid, 2019, 57, 07491581, 919, 10.1002/mrc.4883 | |
3. | Nathalie Barroca, Ana Marote, Sandra I. Vieira, Abílio Almeida, Maria H.V. Fernandes, Paula M. Vilarinho, Odete A.B. da Cruz e Silva, Electrically polarized PLLA nanofibers as neural tissue engineering scaffolds with improved neuritogenesis, 2018, 167, 09277765, 93, 10.1016/j.colsurfb.2018.03.050 | |
4. | Isabel M. Bjørge, Bárbara M. de Sousa, Sónia G. Patrício, Ana Sofia Silva, Liebert P. Nogueira, Lúcia F. Santos, Sandra I. Vieira, Håvard J. Haugen, Clara R. Correia, João F. Mano, Bioengineered Hierarchical Bonelike Compartmentalized Microconstructs Using Nanogrooved Microdiscs, 2022, 14, 1944-8244, 19116, 10.1021/acsami.2c01161 | |
5. | Bárbara M. de Sousa, Clara R. Correia, Jorge A. F. Ferreira, João F. Mano, Edward P. Furlani, Marco P. Soares dos Santos, Sandra I. Vieira, Capacitive interdigitated system of high osteoinductive/conductive performance for personalized acting-sensing implants, 2021, 6, 2057-3995, 10.1038/s41536-021-00184-6 | |
6. | Nick Weir, Bob Stevens, Sarah Wagner, Amanda Miles, Graham Ball, Charlotte Howard, Joseph Chemmarappally, Martin McGinnity, Alan Jeffrey Hargreaves, Chris Tinsley, Aligned Poly-l-lactic Acid Nanofibers Induce Self-Assembly of Primary Cortical Neurons into 3D Cell Clusters, 2022, 8, 2373-9878, 765, 10.1021/acsbiomaterials.1c01102 | |
7. | Luís Nascimento, Cristiana Fernandes, Ricardo. M. Silva, Ângela Semitela, Bárbara M. de Sousa, Paula A. A. P. Marques, Sandra I. Vieira, Rui. F. Silva, Nathalie Barroca, Gil Gonçalves, Customizing 3D Structures of Vertically Aligned Carbon Nanotubes to Direct Neural Stem Cell Differentiation, 2023, 2192-2640, 10.1002/adhm.202300828 |
Band | Identified proteins | Equal emPAIs | Different emPAIs | |||
Upregulated in NanoF | Downregulated in NanoF | |||||
Unique in NanoF | UpR in NanoF | Unique in Control | DownR in NanoF | |||
100 kDa | 29 | 11 | 4 | 2 | 4 | 7 |
80 kDa | 38 | 22 | 3 | 3 | 3 | 6 |
70 kDa | 40 | 17 | 4 | 4 | 2 | 8 |
60 kDa | 27 | 13 | 0 | 2 | 5 | 6 |
Total | 83 | 38 | 6 | 6 | 13 | 20 |
12 | 33 |
Accession number | Protein name | Molecular weight1 | Fold increase | Cellular function | Ref. |
P06396 | Gelsolin | 87 kDa | 3.27* | Cytoskeleton assembly and remodeling | [33,34] |
GELS_HUMAN | (nucleation of actin monomers into filaments and severing of already formed filaments) | ||||
P02765 | Alpha-2-HS-glycoprotein | 39 kDa | 1.52 | ECM stabilization | [30,31] |
FETUA_HUMAN | (extracellular matrix maturation,brain development,endocytosis) | ||||
P19823 | Inter-alpha-trypsin inhibitor heavy chain H2 | 106 kDa | 1.75 | ECM stabilization | [32] |
ITIH2_HUMAN | (intermediate protein between hyaluronan and other matrix protein; inhibitor of neural cells proliferation and inducer of cell-cell adhesion) | ||||
P17844 | Probable ATP-dependent RNA helicase DDX5 | 69 kDa | 0.33 | Protein synthesis | [39] |
DDX5_HUMAN | (involved in the alternative regulation of pre-mRNA splicing) | ||||
Q16643 DREB_HUMAN | Drebrin | 71 kDa | 0.31* | Cytoskeleton assembly and remodeling | [47] |
(required for actin polymerization,cell migration and neuronal plasticity | |||||
Q14195 | Dihydropyrimidinase-related protein 3 | 62 kDa | 0.46 | Cytoskeleton assembly and remodeling | [63] |
DPYL3_HUMAN | (regulation of neuronal growth cone collapse via semaphorins signaling) | ||||
P11021 | 78 kDa glucose-regulated protein | 72 kDa | 0.46 | Protein folding | [41,42] |
GRP78_HUMAN | (ER chaperon; assembly of multimeric protein complexes) | ||||
P08238 | Heat shock protein HSP 90-beta | 83 kDa | 0.41 | Cell proliferation (also protein folding) | [41] |
HS90B_HUMAN | (regulation of proteins involved in cell cycle and signal transduction; chaperon) | ||||
P02545 LMNA_HUMAN | Prelamin-A/C | 74 kDa | 0.32* | DNA replication | [37,38] |
(nuclear assembly and chromatin organization) | |||||
P09874 PARP1_HUMAN | Poly [ADP-ribose] polymerase 1 | 113 kDa | 0,36 | DNA repair | [43,44] |
(reparation of DNA strand breaks and transcription regulator) | |||||
Q00839 HNRPU_HUMAN | Heterogeneous nuclear ribonucleoprotein U | 91 kDa | 0.61 | Protein synthesis | [40] |
(pre-mRNA processing,mRNA metabolism and transport) | |||||
Q07666 KHDR1_HUMAN | KH domain-containing,RNA-binding,signal transduction-associated protein 1 | 48 kDa | 0.50 | Cell proliferation | [35] |
(role in G2-M progression in cell cycle) | |||||
P33992 MCM5_HUMAN | DNA replication licensing factor MCM5 | 82 kDa | 0.57 | DNA replication | [36] |
(component of the MCM complex,a putative replicative helicase,function in DNA replication initiation and elongation) | |||||
P35241 RADI_HUMAN | Radixin | 69 kDa | 0.64 | Cytoskeleton assembly and remodeling | [48] |
(member of the ERM actin regulator proteins. Anchorage of the plasma membrane and the actin cytoskeleton) | |||||
Q13263 TIF1B_HUMAN | Transcription intermediary factor 1-beta | 89 kDa | 0.23 | Protein synthesis | [45,46] |
(regulator of DNA transcription) | |||||
The main proteins whose levels were found altered in cells grown for 11 days on PLLA nanofibers and identified in at least 2 samples of each condition (Control or NanoF) are listed. The Fold Increase (FI) was calculated based on the emPAI, indicator of the protein abundance in the sample; positive FI: up-regulated protein in cells grown on NanoF; negative FI: down-regulated protein in cells grown on NanoF. Asterisk (*) indicates statistical significance (p < 0, 05) of the fold increase; the majority of the proteins is only tendentiously up- or down-regulated. The function of the identified proteins is based on information contained in the indicated references (Ref.). 1Protein molecular weight without considering post-translational modifications. |
Pathway name | Entities pValue | Entities FDR | Submitted entities found | Submitted entities hit interactor | Interacts with |
Signaling by VEGF | 0.0018 | 0.0106 | HS90A_HUMAN | HS90B_HUMAN;KHDR1_HUMAN;U5S1_HUMAN;GRP78_HUMAN;HS90A_HUMAN;HSP71_HUMAN;HSP7C_HUMAN | P04049;P07900;P35916;P31749;P19174;P53041;P06241;P15056;P04792 |
Signaling by PTK6 | 0.0074 | 0.0252 | KHDR1_HUMAN | HS90B_HUMAN;KHDR1_HUMAN;GRP78_HUMAN;HS90A_HUMAN;HSP7C_HUMAN | Q5S007;P31749;Q07666 |
CRMPs in Sema3A signaling | 0.0088 | 0.0265 | DPYL2_HUMAN;DPYL3_HUMAN | - | - |
Cytokine Signaling in Immune system | 0.0316 | 0.0537 | NUP93_HUMAN | MCM7_HUMAN;HS90B_HUMAN;KHDR1_HUMAN;KINH_HUMAN;GRP78_HUMAN;HS90A_HUMAN;LMNA_HUMAN | P04049;Q99558;P15498;P41279;P19838;P07948;P53041;P15056;P63104 |
Signaling by Ligand-Responsive EGFR Variants in Cancer | 0.0353 | 0.0537 | HS90A_HUMAN | KHDR1_HUMAN | P19174 |
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 0.0353 | 0.0537 | HS90A_HUMAN | KHDR1_HUMAN | P19174 |
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | 0.0354 | 0.0537 | HS90B_HUMAN | MCM7_HUMAN;HS90B_HUMAN;HS90A_HUMAN | Q9Y6K9;P08238;Q9Y239 |
Signal Transduction | 0.0547 | 0.0547 | HNRPM_HUMAN; PARP1_HUMAN; | MCM7_HUMAN;HS90B_HUMAN;PARP1_HUMAN;HS90A_HUMAN;SF3A1_HUMAN;LMNA_HUMAN;GANAB_HUMAN;TIF1B_HUMAN;KHDR1_HUMAN;DDX5_HUMAN;U5S1_HUMAN;HNRPU_HUMAN;KINH_HUMAN;GRP78_HUMAN;HSP71_HUMAN;HSP7C_HUMAN;NUP93_HUMAN | P04049;Q13546;Q13547;P05412;P49674;P31749;O15111;P31946;Q07666;P06241;P09874;P09651;P08047;Q01974;P15498;Q9UNE7;P46527;Q12933;P36896;P15056;Q09472;P07900;P35916;Q5S007;P19174;P00533;Q15831;P01106;Q13573;P63104;P04792;P42679;P53041;P32121;P31152 |
KHDR1_HUMAN; | |||||
KINH_HUMAN; | |||||
HS90A_HUMAN | |||||
Signaling by FGFR2 | 0.0561 | 0.0561 | HNRPM_HUMAN | HS90B_HUMAN;KHDR1_HUMAN;GRP78_HUMAN;HS90A_HUMAN | P04049;P31749;O15111;P19174;P53041;P15056;P09651 |
Signaling by FGFR | 0.0579 | 0.0579 | HNRPM_HUMAN | HS90B_HUMAN;KHDR1_HUMAN;GRP78_HUMAN;HS90A_HUMAN | P04049;P31749;O15111;P19174;P53041;P15056;P09651 |
Proteins Upregulated in NanoF | Proteins Downregulated in NanoF | ||
Unique in NanoF | UpR in NanoF | Unique in Control | DownR in NanoF |
Alpha-2-macroglobulin | Serum albumin | Aminopeptidase B | ATP-citrate synthase |
Complement C3 | Alpha-fetoprotein | Cytoskeleton-associated protein 4 | Probable ATP-dependent RNA helicase DDX5 |
Hemoglobin subunit alpha | Alpha-2-HS-glycoprotein | Cytoplasmic dynein 1 intermediate chain 2 | Drebrin |
Hemoglobin subunit beta | Gelsolin | Dipeptidyl peptidase 3 | Dihydropyrimidinase-related protein 3 |
Inter-alpha-trypsin inhibitor heavy chain H4 | Inter-alpha-trypsin inhibitor heavy chain H2 | Dihydropyrimidinase-related protein 2 | 78 kDa glucose-regulated protein |
DNA repair and recombination protein RAD54-like | Septin-9 | Neutral alpha-glucosidase AB | Heat shock protein HSP 90-alpha |
Ras GTPase-activating protein-binding protein 2 | Heat shock protein HSP 90-beta | ||
Kinesin-1 heavy chain | Heat shock 70 kDa protein 1A/1B | ||
DNA replication licensing factor MCM7 | Heat shock cognate 71 kDa protein | ||
Nuclear pore complex protein Nup93 | Interleukin enhancer-binding factor 3 | ||
U4/U6 small nuclear ribonucleoprotein Prp3 | Mitochondrial inner membrane protein | ||
Splicing factor 3A subunit 1 | Prelamin-A/C | ||
116 kDa U5 small nuclear ribonucleoprotein component | Poly [ADP-ribose] polymerase 1 | ||
Heterogeneous nuclear ribonucleoprotein U | |||
Heterogeneous nuclear ribonucleoprotein M | |||
KH domain-containing, RNA-binding, signal transduction-associated protein 1 | |||
DNA replication licensing factor MCM5 | |||
Radixin | |||
Lysosome membrane protein 2 | |||
Transcription intermediary factor 1-beta |
Band | Identified proteins | Equal emPAIs | Different emPAIs | |||
Upregulated in NanoF | Downregulated in NanoF | |||||
Unique in NanoF | UpR in NanoF | Unique in Control | DownR in NanoF | |||
100 kDa | 29 | 11 | 4 | 2 | 4 | 7 |
80 kDa | 38 | 22 | 3 | 3 | 3 | 6 |
70 kDa | 40 | 17 | 4 | 4 | 2 | 8 |
60 kDa | 27 | 13 | 0 | 2 | 5 | 6 |
Total | 83 | 38 | 6 | 6 | 13 | 20 |
12 | 33 |
Accession number | Protein name | Molecular weight1 | Fold increase | Cellular function | Ref. |
P06396 | Gelsolin | 87 kDa | 3.27* | Cytoskeleton assembly and remodeling | [33,34] |
GELS_HUMAN | (nucleation of actin monomers into filaments and severing of already formed filaments) | ||||
P02765 | Alpha-2-HS-glycoprotein | 39 kDa | 1.52 | ECM stabilization | [30,31] |
FETUA_HUMAN | (extracellular matrix maturation,brain development,endocytosis) | ||||
P19823 | Inter-alpha-trypsin inhibitor heavy chain H2 | 106 kDa | 1.75 | ECM stabilization | [32] |
ITIH2_HUMAN | (intermediate protein between hyaluronan and other matrix protein; inhibitor of neural cells proliferation and inducer of cell-cell adhesion) | ||||
P17844 | Probable ATP-dependent RNA helicase DDX5 | 69 kDa | 0.33 | Protein synthesis | [39] |
DDX5_HUMAN | (involved in the alternative regulation of pre-mRNA splicing) | ||||
Q16643 DREB_HUMAN | Drebrin | 71 kDa | 0.31* | Cytoskeleton assembly and remodeling | [47] |
(required for actin polymerization,cell migration and neuronal plasticity | |||||
Q14195 | Dihydropyrimidinase-related protein 3 | 62 kDa | 0.46 | Cytoskeleton assembly and remodeling | [63] |
DPYL3_HUMAN | (regulation of neuronal growth cone collapse via semaphorins signaling) | ||||
P11021 | 78 kDa glucose-regulated protein | 72 kDa | 0.46 | Protein folding | [41,42] |
GRP78_HUMAN | (ER chaperon; assembly of multimeric protein complexes) | ||||
P08238 | Heat shock protein HSP 90-beta | 83 kDa | 0.41 | Cell proliferation (also protein folding) | [41] |
HS90B_HUMAN | (regulation of proteins involved in cell cycle and signal transduction; chaperon) | ||||
P02545 LMNA_HUMAN | Prelamin-A/C | 74 kDa | 0.32* | DNA replication | [37,38] |
(nuclear assembly and chromatin organization) | |||||
P09874 PARP1_HUMAN | Poly [ADP-ribose] polymerase 1 | 113 kDa | 0,36 | DNA repair | [43,44] |
(reparation of DNA strand breaks and transcription regulator) | |||||
Q00839 HNRPU_HUMAN | Heterogeneous nuclear ribonucleoprotein U | 91 kDa | 0.61 | Protein synthesis | [40] |
(pre-mRNA processing,mRNA metabolism and transport) | |||||
Q07666 KHDR1_HUMAN | KH domain-containing,RNA-binding,signal transduction-associated protein 1 | 48 kDa | 0.50 | Cell proliferation | [35] |
(role in G2-M progression in cell cycle) | |||||
P33992 MCM5_HUMAN | DNA replication licensing factor MCM5 | 82 kDa | 0.57 | DNA replication | [36] |
(component of the MCM complex,a putative replicative helicase,function in DNA replication initiation and elongation) | |||||
P35241 RADI_HUMAN | Radixin | 69 kDa | 0.64 | Cytoskeleton assembly and remodeling | [48] |
(member of the ERM actin regulator proteins. Anchorage of the plasma membrane and the actin cytoskeleton) | |||||
Q13263 TIF1B_HUMAN | Transcription intermediary factor 1-beta | 89 kDa | 0.23 | Protein synthesis | [45,46] |
(regulator of DNA transcription) | |||||
The main proteins whose levels were found altered in cells grown for 11 days on PLLA nanofibers and identified in at least 2 samples of each condition (Control or NanoF) are listed. The Fold Increase (FI) was calculated based on the emPAI, indicator of the protein abundance in the sample; positive FI: up-regulated protein in cells grown on NanoF; negative FI: down-regulated protein in cells grown on NanoF. Asterisk (*) indicates statistical significance (p < 0, 05) of the fold increase; the majority of the proteins is only tendentiously up- or down-regulated. The function of the identified proteins is based on information contained in the indicated references (Ref.). 1Protein molecular weight without considering post-translational modifications. |
Pathway name | Entities pValue | Entities FDR | Submitted entities found | Submitted entities hit interactor | Interacts with |
Signaling by VEGF | 0.0018 | 0.0106 | HS90A_HUMAN | HS90B_HUMAN;KHDR1_HUMAN;U5S1_HUMAN;GRP78_HUMAN;HS90A_HUMAN;HSP71_HUMAN;HSP7C_HUMAN | P04049;P07900;P35916;P31749;P19174;P53041;P06241;P15056;P04792 |
Signaling by PTK6 | 0.0074 | 0.0252 | KHDR1_HUMAN | HS90B_HUMAN;KHDR1_HUMAN;GRP78_HUMAN;HS90A_HUMAN;HSP7C_HUMAN | Q5S007;P31749;Q07666 |
CRMPs in Sema3A signaling | 0.0088 | 0.0265 | DPYL2_HUMAN;DPYL3_HUMAN | - | - |
Cytokine Signaling in Immune system | 0.0316 | 0.0537 | NUP93_HUMAN | MCM7_HUMAN;HS90B_HUMAN;KHDR1_HUMAN;KINH_HUMAN;GRP78_HUMAN;HS90A_HUMAN;LMNA_HUMAN | P04049;Q99558;P15498;P41279;P19838;P07948;P53041;P15056;P63104 |
Signaling by Ligand-Responsive EGFR Variants in Cancer | 0.0353 | 0.0537 | HS90A_HUMAN | KHDR1_HUMAN | P19174 |
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 0.0353 | 0.0537 | HS90A_HUMAN | KHDR1_HUMAN | P19174 |
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | 0.0354 | 0.0537 | HS90B_HUMAN | MCM7_HUMAN;HS90B_HUMAN;HS90A_HUMAN | Q9Y6K9;P08238;Q9Y239 |
Signal Transduction | 0.0547 | 0.0547 | HNRPM_HUMAN; PARP1_HUMAN; | MCM7_HUMAN;HS90B_HUMAN;PARP1_HUMAN;HS90A_HUMAN;SF3A1_HUMAN;LMNA_HUMAN;GANAB_HUMAN;TIF1B_HUMAN;KHDR1_HUMAN;DDX5_HUMAN;U5S1_HUMAN;HNRPU_HUMAN;KINH_HUMAN;GRP78_HUMAN;HSP71_HUMAN;HSP7C_HUMAN;NUP93_HUMAN | P04049;Q13546;Q13547;P05412;P49674;P31749;O15111;P31946;Q07666;P06241;P09874;P09651;P08047;Q01974;P15498;Q9UNE7;P46527;Q12933;P36896;P15056;Q09472;P07900;P35916;Q5S007;P19174;P00533;Q15831;P01106;Q13573;P63104;P04792;P42679;P53041;P32121;P31152 |
KHDR1_HUMAN; | |||||
KINH_HUMAN; | |||||
HS90A_HUMAN | |||||
Signaling by FGFR2 | 0.0561 | 0.0561 | HNRPM_HUMAN | HS90B_HUMAN;KHDR1_HUMAN;GRP78_HUMAN;HS90A_HUMAN | P04049;P31749;O15111;P19174;P53041;P15056;P09651 |
Signaling by FGFR | 0.0579 | 0.0579 | HNRPM_HUMAN | HS90B_HUMAN;KHDR1_HUMAN;GRP78_HUMAN;HS90A_HUMAN | P04049;P31749;O15111;P19174;P53041;P15056;P09651 |
Proteins Upregulated in NanoF | Proteins Downregulated in NanoF | ||
Unique in NanoF | UpR in NanoF | Unique in Control | DownR in NanoF |
Alpha-2-macroglobulin | Serum albumin | Aminopeptidase B | ATP-citrate synthase |
Complement C3 | Alpha-fetoprotein | Cytoskeleton-associated protein 4 | Probable ATP-dependent RNA helicase DDX5 |
Hemoglobin subunit alpha | Alpha-2-HS-glycoprotein | Cytoplasmic dynein 1 intermediate chain 2 | Drebrin |
Hemoglobin subunit beta | Gelsolin | Dipeptidyl peptidase 3 | Dihydropyrimidinase-related protein 3 |
Inter-alpha-trypsin inhibitor heavy chain H4 | Inter-alpha-trypsin inhibitor heavy chain H2 | Dihydropyrimidinase-related protein 2 | 78 kDa glucose-regulated protein |
DNA repair and recombination protein RAD54-like | Septin-9 | Neutral alpha-glucosidase AB | Heat shock protein HSP 90-alpha |
Ras GTPase-activating protein-binding protein 2 | Heat shock protein HSP 90-beta | ||
Kinesin-1 heavy chain | Heat shock 70 kDa protein 1A/1B | ||
DNA replication licensing factor MCM7 | Heat shock cognate 71 kDa protein | ||
Nuclear pore complex protein Nup93 | Interleukin enhancer-binding factor 3 | ||
U4/U6 small nuclear ribonucleoprotein Prp3 | Mitochondrial inner membrane protein | ||
Splicing factor 3A subunit 1 | Prelamin-A/C | ||
116 kDa U5 small nuclear ribonucleoprotein component | Poly [ADP-ribose] polymerase 1 | ||
Heterogeneous nuclear ribonucleoprotein U | |||
Heterogeneous nuclear ribonucleoprotein M | |||
KH domain-containing, RNA-binding, signal transduction-associated protein 1 | |||
DNA replication licensing factor MCM5 | |||
Radixin | |||
Lysosome membrane protein 2 | |||
Transcription intermediary factor 1-beta |